Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.35 |
| ▸ | CPA3 | P15088 | 1/20 | 0.32 |
| ▸ | PTGES | O14684 | 1/20 | 0.31 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.31 |
| ▸ | PPARG | P37231 | 1/20 | 0.31 |
| ▸ | HMGCR | P04035 | 2/20 | 0.30 |
| ▸ | VCAM1 | P19320 | 1/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30232797 | 0.88 | GAA (0.39) | CPA3PTGESALOX5PPARGHMGCR | |
| SCHEMBL30232599 | 0.84 | HMGCR (0.40) | NPSR1PTGESALOX5PPARGHMGCR | |
| SCHEMBL106873 | 0.84 | HMGCR (0.40) | NPSR1PTGESALOX5PPARGHMGCR | |
| SCHEMBL16507180 | 0.83 | NPSR1 (0.50) | NPSR1PPARGVCAM1 | |
| SCHEMBL29409721 | 0.81 | HSPA5 (0.38) | NPSR1CPA3PTGESALOX5PPARG | |
| SCHEMBL18783187 | 0.80 | GAA (0.37) | CPA3PTGESALOX5PPARGHMGCR | |
| SCHEMBL3251285 | 0.79 | HMGCR (0.39) | NPSR1PTGESALOX5PPARGHMGCR | |
| SCHEMBL8954729 | 0.78 | HMGCR (0.46) | NPSR1PTGESALOX5PPARGHMGCR | |
| SCHEMBL11619679 | 0.77 | HMGCR (0.47) | NPSR1PTGESALOX5PPARGHMGCR | |
| SCHEMBL29228065 | 0.76 | CYP1A2 (0.45) | NPSR1HMGCRMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3330751-B1 | METHOD OF PRODUCING A PHOTOCHROMIC LAMINATE | TOKUYAMA CORP (JP) | 2021-05-26 | — | — | EP | disclosed |
| EP-2966102-B1 | CURABLE PHOTOCHROMIC COMPOSITION, CURED PRODUCT THEREOF, AND LAMINATE INCLUDING CURED PRODUCT | TOKUYAMA CORP (JP) | 2019-03-27 | — | — | EP | disclosed |
| US-20180251657-A1 | PRIMER COMPOSITION AND PHOTOCHROMIC LAMINATE | TOKUYAMA CORPORATION (JP) | 2018-09-06 | — | — | US | disclosed |
| US-20180244931-A1 | PHOTOCHROMIC COATING COMPOSITION | TOKUYAMA CORPORATION (JP) | 2018-08-30 | — | — | US | disclosed |
| EP-3333602-A1 | PRIMER COMPOSITION AND PHOTOCHROMIC LAYERED BODY | Tokuyama Corporation (JP) | 2018-06-13 | — | — | EP | disclosed |
| EP-3330751-A1 | PHOTOCHROMIC COATING COMPOSITION | Tokuyama Corporation (JP) | 2018-06-06 | — | — | EP | disclosed |
| US-9890324-B2 | Photochromic curable composition, cured product thereof and laminate including the cured product | TOKUYAMA CORPORATION (JP) | 2018-02-13 | — | — | US | disclosed |
| EP-2966144-B1 | PHOTOCHROMIC CURABLE COMPOSITION | TOKUYAMA CORP (JP) | 2017-10-25 | — | — | EP | disclosed |
| EP-2966144-A1 | PHOTOCHROMIC CURABLE COMPOSITION | Tokuyama Corporation (JP) | 2016-01-13 | — | — | EP | disclosed |
| EP-2966102-A1 | CURABLE PHOTOCHROMIC COMPOSITION, CURED PRODUCT THEREOF, AND LAMINATE INCLUDING CURED PRODUCT | Tokuyama Corporation (JP) | 2016-01-13 | — | — | EP | disclosed |
| US-20160002524-A1 | PHOTOCHROMIC CURABLE COMPOSITION, CURED PRODUCT THEREOF AND LAMINATE INCLUDING THE CURED PRODUCT | TOKUYAMA CORPORATION (JP) | 2016-01-07 | — | — | US | disclosed |
| US-20150368552-A1 | PHOTOCHROMIC CURABLE COMPOSITION | TOKUYAMA CORPORATION (JP) | 2015-12-24 | — | — | US | disclosed |
| EP-2843025-A1 | PHOTOCHROMIC CURABLE COMPOSITION | Tokuyama Corporation (JP) | 2015-03-04 | — | — | EP | disclosed |
| US-20150030866-A1 | PHOTOCHROMIC CURABLE COMPOSITION | TOKUYAMA CORPORATION (JP) | 2015-01-29 | — | — | US | disclosed |
| US-8066917-B2 | Photochromic curable composition | TOKUYAMA CORPORATION (JP) | 2011-11-29 | — | — | US | disclosed |
| US-20100230650-A1 | PHOTOCHROMIC CURABLE COMPOSITION | GULFSTREAM INC. (CA) | 2010-09-16 | — | — | US | disclosed |
| EP-2221325-A1 | PHOTOCHROMIC CURABLE COMPOSITION | Tokuyama Corporation (JP) | 2010-08-25 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150368552-A1 | PHOTOCHROMIC CURABLE COMPOSITION | H1-0, CDH1, COL1A1 | NPSR1 3766/4885CPA3 4339/4885PTGES 196/4885 |
| US-20180244931-A1 | PHOTOCHROMIC COATING COMPOSITION | CDH1, RPA3, VIM | NPSR1 3049/4885CPA3 2132/4885PTGES 1817/4885 |
| US-20150030866-A1 | PHOTOCHROMIC CURABLE COMPOSITION | CRYAA, AHCY, WDR1 | NPSR1 4386/4885CPA3 3456/4885PTGES 448/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.